News

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...
Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...
National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...
Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.
As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...